Gus Lawlor

Insider profile

Currently holds positions in Gyre Therapeutics, Inc., Globeimmune Inc, Human Genome Sciences Inc and Cardiovascular Systems Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Gyre Therapeutics, Inc. Feb. 15, 2018 -
Independent Director Globeimmune Inc June 1, 2003 -
Independent Director Human Genome Sciences Inc March 3, 2004 -
Independent Director Cardiovascular Systems Inc Feb. 1, 2009 -
Independent Director Gyre Therapeutics, Inc. Aug. 20, 2015 - Feb. 15, 2018
Gus Lawlor's trades of Gyre Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-25 2020-02-25
S Sale
72,279 +23.9%
73.43
US$2,821,348 		72,279 +23.9% 73.43 US$2,821,348
2019-02-05 2019-02-05
B Purchase
13,043 -38.7%
386.73
US$947,448 		13,043 -38.7% 386.73 US$947,448
2017-11-16 2017-11-14
B Purchase
43,333 -9.6%
457.68
US$1,691,001 		43,333 -9.6% 457.68 US$1,691,001